ArticleJTO clinical and research reports2026

Brief Report: Multi-Institution Real-World Analysis Evaluating Safety, Efficacy, and ctDNA Dynamics After Tarlatamab in Patients With Previously Treated SCLC and LCNEC.

Graeme Fenton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.